We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2025. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer”
by Abdul Rehman, Shakta Mani Satyam, Mohamed El-Tanani, Sainath Prabhakar, Rashmi Kumari, Prakashchandra Shetty, Sara S. N. Mohammed, Zaina Nafees and Basma Alomar
Cancers 2025, 17(15), 2466; https://doi.org/10.3390/cancers17152466
Available online: https://www.mdpi.com/2072-6694/17/15/2466

“Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions”
by Saeed Rafii, Deborah Mukherji, Ashok Sebastian Komaranchath, Charbel Khalil, Faryal Iqbal, Siddig Ibrahim Abdelwahab, Amin Abyad, Ahmad Y. Abuhelwa, Lakshmikanth Gandikota and Humaid O. Al-Shamsi
Cancers 2025, 17(17), 2898; https://doi.org/10.3390/cancers17172898
Available online: https://www.mdpi.com/2072-6694/17/17/2898

“Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives”
by Omar Alomari, Habiba Eyvazova, Beyzanur Güney, Rana Al Juhmani, Hatice Odabasi, Lubna Al-Rawabdeh, Muhammed Edib Mokresh, Ufuk Erginoglu, Abdullah Keles and Mustafa K. Baskaya
Cancers 2025, 17(15), 2550; https://doi.org/10.3390/cancers17152550
Available online: https://www.mdpi.com/2072-6694/17/15/2550

“Advances and Challenges in the Management of Myelodysplastic Syndromes”
by Jessica M. Stempel, Tariq Kewan and Amer M. Zeidan
Cancers 2025, 17(15), 2469; https://doi.org/10.3390/cancers17152469
Available online: https://www.mdpi.com/2072-6694/17/15/2469

“Chronic Lymphocytic Leukemia: Novel Therapeutic Targets Under Investigation”
by Madhavi Nayyar, Ricardo C. B. de Menezes, Sikander Ailawadhi and Ricardo D. Parrondo
Cancers 2025, 17(14), 2298; https://doi.org/10.3390/cancers17142298
Available online: https://www.mdpi.com/2072-6694/17/14/2298

“Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort”
by Collins Wangulu, Davidson Zhao, Qianghua Zhou, Cuihong Wei, Rajat Kumar, Aaron Schimmer and Hong Chang
Cancers 2025, 17(9), 1405; https://doi.org/10.3390/cancers17091405
Available online: https://www.mdpi.com/2072-6694/17/9/1405

Special Issues:

“Advances in the Treatment of Relapsed and Refractory Multiple Myeloma: Novel Agents, Immunotherapies and Beyond: 2nd Edition”
Guest Editors: Prof. Dr. Klaus Podar and Prof. Dr. Xavier Leleu
Submission deadline: 15 March 2026

“Immunotherapy in Urothelial Carcinoma”
Guest Editor: Dr. Akinori Minato
Submission deadline: 31 March 2026

“Immune Landscape of Renal Cell Carcinoma”
Guest Editors: Dr. Scott S. Tykodi and Dr. Yuexin Xu
Submission deadline: 20 April 2026

“Immune-Related Adverse Events in Cancer Immunotherapy”
Guest Editors: Dr. Kate Young and Dr. Anna Olsson-Brown
Submission deadline: 15 May 2026

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office